Institute of Pathology

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making (2018) Worst TS, Weis CA, Stoehr R, Bertz S, Eckstein M, Otto W, Breyer J, et al. Journal article Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials (2018) Von Den Gruen JM, Hartmann A, Fietkau R, Ghadimi M, Liersch T, Hohenberger W, Weitz J, et al. Journal article Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS) (2018) Gebrekidan M, Erber R, Hartmann A, Fasching P, Emons J, Beckmann M, Bräuer A Journal article Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup (2018) Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, Raisanen JM, et al. Journal article Submandibular gland pleomorphic adenoma: Histopathological capsular characteristics and correlation with the surgical outcome (2018) Mantsopoulos K, Goncalvesa M, Koch M, Iro H, Agaimy A Journal article The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer (2018) Brennan M, Gaß P, Häberle L, Wang D, Hartmann A, Lux MP, Beckmann M, et al. Journal article Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians (2018) Gaß P, Untch M, Mueller V, Moebus V, Thomssen C, Häberle L, Erber R, et al. Journal article EGFR Mutation Testing Using Liquid Biopsy Technology for Patients with Advanced EGFR-Mutant NSCLC (2018) Seitz J, Moskalev E, Fuchs F, Haller F, Hartmann A Conference contribution Correlation of Hif1a expression of primary oral squamous cell carcinomas with histomorphologic parameters and macrophage polarization (2018) Wehrhan F, Möbius P, Amann KU, Geppert CI, Preidl R, Ries J, Neukam FW, Weber M Conference contribution Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria (2018) Hoyer J, Vasileiou G, Uebe S, Wunderle M, Kraus C, Fasching P, Thiel C, et al. Journal article